EP2900061
METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.9.2013EP published:
22.1.2020EP application number:
13837458.2
EPO information:
European Patent Register
Max expiry date:
16.9.2033
Title:
METHOD FOR ENHANCING SPECIFIC IMMUNOTHERAPIES IN CANCER TREATMENT
Timeline
Today
17.9.2013EP application
22.1.2020EP Publication
Owner
Name:
Galectin Therapeutics Inc.Address:
4960 Peachtree Industrial Blvd. Suite 240, Norcross, GA 30071, US
Name:
Providence Health & Services Oregon d/b/a Earle A. Chiles Research Institute of the Robert W. Franz Cancer Res. Cent. at Providence Port. Med. Cen.Address:
4805 NE Gilsan Street, 2N35, Portland, OR 97213, US
Inventor
Name:
TRABER, Peter, G.Address:
Johns Creek, GA 30022, US
Name:
REDMOND, William,L.Address:
Portland, Oregon 97213, US
Name:
ZOMER, EliezerAddress:
Newton, MA 02459, US
Name:
KLYOSOV, AnatoleAddress:
Newton, MA 02459, US
Name:
LINCH, Stefanie, N.Address:
Portland, OR 97213, US
Priority
Number:
201261701914 PDate:
17.9.2012Country:
US
Number:
201361756818 PDate:
25.1.2013Country:
US
Number:
201361759532 PDate:
1.2.2013Country:
US
Classification
Categories:
A01N 43/04, C07H 15/04